nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2024, 06, v.43 598-602
加味五苓肾气汤治疗糖尿病黄斑水肿的疗效及机制研究
基金项目(Foundation): 广州市科技计划项目(编号:2023A03J0774)
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2024.06.008
发布时间: 2024-06-05
出版时间: 2024-06-05
移动端阅读
摘要:

目的:观察加味五苓肾气汤治疗脾肾阳虚型糖尿病黄斑水肿(DME)的临床疗效,并探究相关机制。方法:将120例DME患者按随机数字表法分为观察组和对照组各60例。两组患者均予黄斑区格栅光凝治疗,观察组在此基础上予加味五苓肾气汤治疗,两组均以1周为1个疗程,共治疗4个疗程。比较两组治疗后的临床疗效,以及治疗前后中医证候积分、视网膜中央动脉(CRA)血流动力学参数[收缩期峰值流速(PSV)、舒张末期血流速度(EDV)、阻力指数(RI)]、最佳矫正视力(BCVA)、黄斑中心凹视网膜厚度(CRT)、疾病相关因子[白细胞介素-1β(IL-1β)、载脂蛋白B/载脂蛋白A-1(ApoB/ApoA-1)]水平。结果:治疗后,观察组总有效率95.00%,高于对照组(P<0.05);两组中医证候积分、CRT、IL-1β水平、ApoB/ApoA-1均低于本组治疗前(P<0.05),且观察组低于对照组(P<0.05);两组PSV、BCVA均高于本组治疗前(P<0.05),且观察组高于对照组(P<0.05)。结论:加味五苓肾气汤治疗DME疗效确切,可有效缓解患者中医症状、提升视力,其机制可能与改善视网膜血流动力学、减轻机体炎症及调节脂代谢紊乱有关。

Abstract:

Objective:To observe the therapeutic effect of Modified Wuling Shenqi Decoction(加味五苓肾气汤) in treating diabetic macular edema(DME) caused by spleen-kidney yang deficiency,and to explore the related mechanisms. Methods:A total of 120 DME patients were divided into an observation group and a control group by the random number table method,with 60 cases in each group. Both groups received macular grid photocoagulation treatment,and the observation group was additionally treated with Modified Wuling Shenqi Decoction. Each course of treatment lasted for 1 week,and a total of 4 courses were administered. Comparisons were made between the two groups in terms of therapeutic effect after treatment,as well as traditional Chinese medicine(TCM) syndrome scores,hemodynamic parameters of central retinal artery(CRA) [peak systolic velocity(PSV),end-diastolic velocity(EDV),resistance index(RI)],best corrected visual acuity(BCVA),central retinal thickness(CRT) in macular fovea,and levels of disease-related factors [interleukin-1β(IL-1β),apolipoprotein B/apolipoprotein A-1(Apo B/Apo A-1)] before and after treatment. Results:After treatment,the total effective rate in the observation group(95.00%) was higher than that in the control group(P<0.05). The TCM syndrome scores,CRT,IL-1β level and Apo B/Apo A-1 in both groups were decreased after treatment,with the observation group showing a more significant decrease compared to the control group(P<0.05). The levels of PSV and BCVA in both groups were increased after treatment,with the observation group showing a more significant increase compared to the control group(P<0.05). Conclusions:The Modified Wuling Shenqi Decoction has definite therapeutic effect in treating DME. It can effectively relieve the patients ' TCM symptoms and enhance their visual acuity. The mechanism may be related to improving retinal hemodynamics,reducing inflammation,and regulating lipid metabolism disorder.

参考文献

[1]XU Y,WANG L M,HE J,et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013,310(9):948-958.

[2]ZOU C,HAN C J,ZHAO M J,et al. Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis[J]. Clin Proteomics,2018,15:12.

[3]翟军印,陆亚玲,张艺.交泰归芍方联合玻璃体切割术治疗增殖性糖尿病视网膜病变合并黄斑水肿临床研究[J].山东中医杂志,2023,42(1):38-44.

[4]陈梅,曾志成,彭俊,等.益气养阴活血利水复方联合玻璃体腔注射康柏西普对糖尿病黄斑水肿患者玻璃体液HIF-1α和VEGF表达影响[J].中国中西医结合杂志,2020,40(2):149-153.

[5]吕怡,蒋鹏飞,胡艺,等.基于腠理学说论治黄斑水肿[J].中医杂志,2022,63(13):1227-1230.

[6]李筱荣,黎晓新,惠延年.糖尿病眼病[M].北京:人民卫生出版社,2010:114.

[7]彭清华.中医眼科学[M].北京:中国中医药出版社,2016:176-177.

[8]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:312-315.

[9]姚婕,曹丹,曾运考,等.影响糖尿病黄斑水肿治疗效果的全身因素研究进展[J].中华眼底病杂志,2022,38(3):253-256.

[10]金琪,郝晓凤,谢立科,等.视网膜静脉阻塞继发黄斑水肿与炎症的关系及其抗炎治疗研究进展[J].山东医药,2020,60(35):105-108.

[11]吴豪,王菁,陈茜,等.中药联合抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的疗效观察[J].时珍国医国药,2020,31(1):117-120.

[12]李翔,邓颖,李新宇,等. 2型糖尿病眼底体征与中医证素的相关性研究[J].湖南中医药大学学报,2021,41(7):1073-1078.

[13]秦裕辉.问目哪得清如许,唯有活血利水来:评《眼科活血利水法的研究》[J].湖南中医药大学学报,2020,40(3):381-382.

[14]彭清华,曾志成,彭俊,等.黄斑水肿的中医药治疗[J].中国中医眼科杂志,2020,30(6):381-385.

[15]聂立聪,毕徐齐,佟彤,等.基于扶阳理论探讨辛温药在干眼的临床应用[J].中国中医眼科杂志,2023,33(4):354-357.

[16]王真艳,陈晓莉,李雪瑶,等.血清脂蛋白比值与糖尿病黄斑水肿发生及严重程度的相关性分析[J].眼科,2019,28(6):451-453.

[17]胡邵宁,朱书渊,魏燕斌.血清脂蛋白a水平及三酰甘油与高密度脂蛋白胆固醇比值与2型糖尿病视网膜病变的相关性研究[J].中国卫生检验杂志,2022,32(2):205-208.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2024.06.008

中图分类号:R259;R276.7

引用信息:

[1]李建良,杜红彦,骆煌,等.加味五苓肾气汤治疗糖尿病黄斑水肿的疗效及机制研究[J].山东中医杂志,2024,43(06):598-602.DOI:10.16295/j.cnki.0257-358x.2024.06.008.

基金信息:

广州市科技计划项目(编号:2023A03J0774)

发布时间:

2024-06-05

出版时间:

2024-06-05

检 索 高级检索